Ribonucleotide reductase catalyzes the rate-limiting step in the de novo synthesis of the dNTPs that are required for DNA replication. This enzyme consists of two non-identical protein subunits [a non-heme iron (NHI) and effector-binding (EB) subunit. The synthesis/degradation of the two protein subunits are not coordinately regulated as the cells traverse the cell cycle. The separate genes which encode for these subunits are likewise not under coordinate control. The individual subunits can be specifically and independently inhibited/inactivated by defined classes of drugs. Since the development of drug resistance is a common phenomenon in tumor cells and the mechanisms of resistance can be varied and multiple, drug resistance at the ribonucleotide reductase site can be developed at either subunit or both subunits simultaneously. The mechanisms of resistance will be based on changes quantitatively or qualitatively in the non-heme iron or effector-binding subunits. In the proposed studies, we will in a systematic manner investigate the mechanisms of resistance which are developed at the ribonucleotide reductase site in mouse leukemia L1210 cells. We will determine the levels of resistance to specific ribonucleotide reductase inhibitors, cross-resistance patterns, the levels of enzyme activity and subunit concentrations, the properties of the subunits and the enzyme in the resistance cells, the levels of the mRNAs for the NHI and EB subunits and the gene copy number and DNA sequence if warranted for each subunit compared to the wild-type cells. The overall goal of this project is to define the biochemical and molecular mechanisms by which resistance to inhibitors of ribonucleotide reductase that are specifically and independently directed at either the non-heme iron or effector-binding subunits are developed. Further, these resistant cell lines will be useful in discerning subtle differences, at the cellular level, in the mechanisms of inhibition at the ribonucleotide reductase site between apparently similar drugs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA055540-02
Application #
3200027
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1992-08-01
Project End
1996-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
East Carolina University
Department
Type
Schools of Medicine
DUNS #
City
Greenville
State
NC
Country
United States
Zip Code
27858
Hall, J G; Cory, A H; Hickerson, D H et al. (2001) Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cells. Anticancer Res 21:173-80
Somerville, L; Cory, J G (2000) Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to apoptosis induced by 7-hydroxystaurosporine. Int J Oncol 17:797-803
Somerville, L; Cory, J G (2000) Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells. Anticancer Res 20:3347-55
Somerville, L; Cory, J G (1999) Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to various kinase inhibitors. Anticancer Res 19:1021-6
He, A W; Cory, J G (1999) p53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines. Anticancer Res 19:421-8
Finch, R A; Liu, M C; Cory, A H et al. (1999) Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone;3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity. Adv Enzyme Regul 39:3-12
Hall, J G; Cory, A H; Cory, J G (1999) Lack of competition of substrates for P-glycoprotein in MCF-7 breast cancer cells overexpressing MDR1. Adv Enzyme Regul 39:113-28
Cory, A H; Cory, J G (1998) Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine. Biochem Biophys Res Commun 249:687-91
Cory, A H; He, A W; Cory, J G (1998) Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents. Adv Enzyme Regul 38:3-18
He, A W; Cory, J G (1998) Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells. Oncol Res 10:455-64

Showing the most recent 10 out of 21 publications